Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Mitral valve prolapse and left ventricular systolic function.

Malev E, Zemtsovsky E.

Cardiol Young. 2015 Aug;25(6):1232. No abstract available.

PMID:
26355181
2.

Preoperative left ventricular function in degenerative mitral valve disease.

Malev E, Kim G, Mitrofanova L, Zemtsovsky E.

J Cardiovasc Med (Hagerstown). 2014 Mar;15(3):222-9. doi: 10.2459/JCM.0b013e328362784f.

PMID:
23884089
3.

Cardiomyopathy in young adults with classic mitral valve prolapse.

Malev E, Reeva S, Vasina L, Timofeev E, Pshepiy A, Korshunova A, Prokudina M, Zemtsovsky E.

Cardiol Young. 2014 Aug;24(4):694-701. doi: 10.1017/S1047951113001042. Epub 2013 Jul 23.

PMID:
23880103
4.

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators.

Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum in: Lancet Neurol. 2012 Dec;11(12):1021.

PMID:
22572202
5.

Evaluation of left ventricular systolic function in young adults with mitral valve prolapse.

Malev E, Zemtsovsky E, Pshepiy A, Timofeev E, Reeva S, Prokudina M.

Exp Clin Cardiol. 2012 Winter;17(4):165-8.

6.

Rivaroxaban in patients with a recent acute coronary syndrome.

Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators.

N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.

7.

Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators.

N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.

8.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].

PMID:
20801500
9.

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators.

N Engl J Med. 2003 Nov 13;349(20):1893-906. Epub 2003 Nov 10. Erratum in: N Engl J Med. 2004 Jan 8;350(2):203.

10.

[Intravenous drip method used in first aid].

Zemtsovsky EV.

Med Sestra. 1966 Feb;25(2):45-6. Russian. No abstract available.

PMID:
5175961

Supplemental Content

Loading ...
Support Center